Abstract: An electroluminescent device includes a first electrode and a second electrode facing each other; a quantum dot layer disposed between the first electrode and the second electrode and including a plurality of quantum dots; optionally, an electron transport layer between the quantum dot layer and the second electrode; wherein the quantum dot layer is configured to emit first light. The electroluminescent device further includes a first layer including an inorganic nanoparticle between the quantum dot layer and the first electrode, and inorganic nanoparticle includes a metal chalcogenide including a Group II metal and a chalcogen element. The inorganic nanoparticle has a size of greater than or equal to about 0.5 nanometers and less than or equal to about 30 nanometers.

Abstract: An injection mold apparatus of a pressure vessel includes an upper mold including an internal surface in a shape corresponding to a shape of an external surface of the pressure vessel provided with a nozzle with a closed inlet; a lower mold including an external surface in a shape corresponding to the shape of the internal surface of the pressure vessel, engaged with the upper mold, and formed with an air injection passage therein; an ejector injecting air through the air injection passage between the lower mold and the taken-out pressure vessel; an air injection rate setting device configured for controlling an injection rate of the air injected between the lower mold and the pressure vessel using the ejector; and a pneumatic controller interlocking with the air injection rate setting device and controlling a pressure of air injected.

Abstract: The present invention relates to: a pharmaceutical composition for preventing or treating LDL cholesterol-related diseases, containing a ribosome-binding preparation; a food composition; and a method for preventing or treating LDL cholesterol-related diseases by using the composition. According to the present invention, the ribosome-binding preparation selectively increases the expression of an LDL receptor in intestinal epithelial cells so as to promote LDL absorption in blood and tissue, such that LDL level in the blood can be reduced, thereby being useful for preventing or treating various LDL cholesterol-related diseases including LDL hypercholesterolemia, hyperlipidemia, hypertension and apoplexy.

Abstract: The present invention relates to: a pharmaceutical composition for preventing or treating LDL cholesterol-related diseases, containing a ribosome-binding preparation; a food composition; and a method for preventing or treating LDL cholesterol-related diseases by using the composition. According to the present invention, the ribosome-binding preparation selectively increases the expression of an LDL receptor in intestinal epithelial cells so as to promote LDL absorption in blood and tissue, such that LDL level in the blood can be reduced, thereby being useful for preventing or treating various LDL cholesterol-related diseases including LDL hypercholesterolemia, hyperlipidemia, hypertension and apoplexy.

Abstract: Example embodiments of the present invention disclosed herein relate to an electronic device having a power-down mode. The electronic device includes a regulator, a central processing unit, and an interrupt control unit. The regulator is disabled during the power-down mode to reduce consumption of power.

Abstract: Example embodiments of the present invention disclosed herein relate to an electronic device having a power-down mode. The electronic device includes a regulator, a central processing unit, and an interrupt control unit. The regulator is disabled during the power-down mode to reduce consumption of power.

Abstract: A trench-gate power semiconductor device and a method for fabricating the same are provided.

Abstract: A trench-gate power semiconductor device and a method for fabricating the same are provided.